Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edouard L Fu

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 15, 2018
Merits and caveats of propensity scores to adjust for confoundingEdouard L Fu, Rolf H H Groenwold, Carmine Zoccali, et al.
Clinical Kidney Journal|January 17, 2022
An introduction to inverse probability of treatment weighting in observational researchNicholas C Chesnaye, Vianda S Stel, Giovanni Tripepi, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|December 20, 2024
Kidney Function, Kidney Function Decline, and the Risk of Abdominal Aortic Aneurysm: The Stockholm CREAtinine Measurements (SCREAM) ProjectShigeru Tanaka, Alessandro Bosi, Edouard L Fu, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 9, 2025
Risk-based referral model to nephrologist-specialist care in StockholmAurora Caldinelli, Anne-Laure Faucon, Arvid Sjölander, et al.
Clinical Kidney Journal|May 7, 2021
Pharmacoepidemiology for nephrologists (part 2): potential biases and how to overcome themEdouard L Fu, Merel van Diepen, Yang Xu, et al.
Kidney International|November 7, 2022
Association between cholinesterase inhibitors and kidney function decline in patients with Alzheimer's dementiaHong Xu, Sara Garcia-Ptacek, Annette Bruchfeld, et al.
JAMA Internal Medicine|August 12, 2024
GLP-1RA vs DPP-4i Use and Rates of Hyperkalemia and RAS Blockade Discontinuation in Type 2 DiabetesTao Huang, Alessandro Bosi, Anne-Laure Faucon, et al.
Kidney International|December 15, 2023
A population-based cohort defined risk of hyperkalemia after initiating SGLT-2 inhibitors, GLP1 receptor agonists or DPP-4 inhibitors to patients with chronic kidney disease and type 2 diabetesEdouard L Fu, Julianna Mastrorilli, Katsiaryna Bykov, et al.
European Heart Journal|June 1, 2023
Sodium-glucose cotransporter 2 inhibitors vs. sitagliptin in heart failure and type 2 diabetes: an observational cohort studyEdouard L Fu, Elisabetta Patorno, Brendan M Everett, et al.
Kidney International Reports|March 8, 2022
Kidney Function, Kidney Replacement Therapy, and Mortality in Men and WomenSebastian Hödlmoser, Juan Jesus Carrero, Amelie Kurnikowski, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 15, 2018
Merits and caveats of propensity scores to adjust for confoundingEdouard L Fu, Rolf H H Groenwold, Carmine Zoccali, et al.
Clinical Kidney Journal|January 17, 2022
An introduction to inverse probability of treatment weighting in observational researchNicholas C Chesnaye, Vianda S Stel, Giovanni Tripepi, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|December 20, 2024
Kidney Function, Kidney Function Decline, and the Risk of Abdominal Aortic Aneurysm: The Stockholm CREAtinine Measurements (SCREAM) ProjectShigeru Tanaka, Alessandro Bosi, Edouard L Fu, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 9, 2025
Risk-based referral model to nephrologist-specialist care in StockholmAurora Caldinelli, Anne-Laure Faucon, Arvid Sjölander, et al.
Clinical Kidney Journal|May 7, 2021
Pharmacoepidemiology for nephrologists (part 2): potential biases and how to overcome themEdouard L Fu, Merel van Diepen, Yang Xu, et al.
Kidney International|November 7, 2022
Association between cholinesterase inhibitors and kidney function decline in patients with Alzheimer's dementiaHong Xu, Sara Garcia-Ptacek, Annette Bruchfeld, et al.
JAMA Internal Medicine|August 12, 2024
GLP-1RA vs DPP-4i Use and Rates of Hyperkalemia and RAS Blockade Discontinuation in Type 2 DiabetesTao Huang, Alessandro Bosi, Anne-Laure Faucon, et al.
Kidney International|December 15, 2023
A population-based cohort defined risk of hyperkalemia after initiating SGLT-2 inhibitors, GLP1 receptor agonists or DPP-4 inhibitors to patients with chronic kidney disease and type 2 diabetesEdouard L Fu, Julianna Mastrorilli, Katsiaryna Bykov, et al.
European Heart Journal|June 1, 2023
Sodium-glucose cotransporter 2 inhibitors vs. sitagliptin in heart failure and type 2 diabetes: an observational cohort studyEdouard L Fu, Elisabetta Patorno, Brendan M Everett, et al.
Kidney International Reports|March 8, 2022
Kidney Function, Kidney Replacement Therapy, and Mortality in Men and WomenSebastian Hödlmoser, Juan Jesus Carrero, Amelie Kurnikowski, et al.
Pageof 8